Dermatologic ACLY inhibitors may be useful for treating psoriasis May 27, 2024 Psoriasis is an inflammatory skin disease in which lipid metabolism is often dysregulated. ATP-citrate synthase (ACLY) is known to play a key role in lipid metabolism, but its involvement in psoriasis is not well understood.Read More
Gastrointestinal Esperion Therapeutics discovers new ACLY inhibitors Nov. 28, 2023 Esperion Therapeutics Inc. has described ATP citrate lyase (ACLY) inhibitors reported to be useful for the treatment of cancer and more.Read More